Drug
Ramosetron clinical trials
Also written YM060 and Irribow.
- studies test it
- 44
- open now
- 2
- in phase 3
- 9
- first study started
- 2005
Keep track of what changes. Save the ramosetron studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Development codes
Studies by the year they started
43 studies that test it; most in 2010 (6)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 9
- Phase 4
- 13
- No phase
- 13
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 34
Astellas Pharma Inc (10) · Seoul National University Hospital (10) · Yonsei University (6) · Hallym University Medical Center (3) · Seoul National University Bundang Hospital (2) · Kyunghee University Medical Center (2) · Pusan National University Hospital (1) · Vanderbilt University (1)
Often tested with
Tested in the same studies.
Dexamethasone (6) · Aprepitant (4) · Ondansetron (4) · Palonosetron (2) · Propofol (1) · Sevoflurane (1) · Isoflurane (1) · Desflurane (1)
Studies
Open first, then newest update. How each study uses ramosetron is read from its arms, and is right about nine times in ten.
Testing it · 44
- The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal IncontinenceNot yet recruitingPhase 2/3Seoul National University HospitalNCT06166615Written as Ramosetron
- 5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)RecruitingNot applicableSeoul National University HospitalNCT05577845Written as Ramosetron
- Ramosetron on Late PONV (Postoperative Nausea and Vomiting)CompletedPhase 4Pusan National University HospitalNCT05326360Written as Ramosetron Hydrochloride
- Ramosetron OD Tablet and Postdischarge Nausea and VomitingStatus unknownPhase 4Seoul National University HospitalNCT04297293Written as Ramosetron
- Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg PositionCompletedNot applicableYonsei UniversityNCT03232125Written as Ramosetron
- Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNot applicableVanderbilt UniversityNCT02625181Written as Ramosetron
- Therapeutic Efficacy of Ramosetron for Treatment of Established PONV After Laparoscopic SurgeryCompletedNot applicableYonsei UniversityNCT03017222Written as Ramosetron
- Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and DexamethasoneCompletedPhase 4Kangdong Sacred Heart HospitalNCT02532634Written as ramosetron, aprepitant, dexamethasone
- Effect of Ramosetron on Post-discharge Nausea and VomitingStatus unknownNot applicableSeoul National University Bundang HospitalNCT03409835Written as Ramosetron
- Ramosetron Pre-treatment for PONV and QT ProlongationCompletedPhase 4Konkuk University Medical CenterNCT03278522Written as Ramosetron
- Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 PolymorphismCompletedPhase 4Yonsei UniversityNCT02480088Written as Ramosetron
- A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and NauseaCompletedPhase 3Astellas Pharma IncNCT00272285Written as Ramosetron
- Effect of Ramosetron on Bowel Motility After Gynecological SurgeryStatus unknownPhase 4Kyunghee University Medical CenterNCT02849483Written as Ramosetron
- Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection SyndromeStatus unknownEarly Phase 1Seoul National University HospitalNCT02869984Written as Ramosetron
- Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and VomitingCompletedPhase 3Thammasat UniversityNCT02830906Written as ramosetron
- Post-operative Nausea Vomiting in Laparoscopic CholecystectomyStatus unknownPhase 4Government Medical College, HaldwaniNCT02803788Written as ramosetron, ondansetron, dexamethasone
- Efficacy Study of Antiemetics to Reduce Postoperative Nausea and VomitingCompletedPhase 2Seoul National University HospitalNCT01806948Written as Ramosetron
- Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled AnalgesiaCompletedNot applicableKyungpook National University HospitalNCT02416115Written as Ramosetron
- The Effects of Gabapentin and Ramosetron on Postoperative Nausea and Vomiting in Laparoscopic Gynecological SurgeryStatus unknownNot applicableHallym University Medical CenterNCT02617121Written as Ramosetron
- The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass SurgeryCompletedNot applicableSeoul National University HospitalNCT02139241Written as Ramosetron
See all 44 studies that test ramosetron →
Given in every arm · 1 — ramosetron is usual care beside what is tested
As the comparator · 1 — what is tested is compared with ramosetron
Codes
What other systems call ramosetron · ClinicalTrials.gg INT003593
- MeSH (NLM) C071315ramosetronConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7ZRO0SC54YRAMOSETRONConfirmed FDA, NLM, Wikidata
- Wikidata Q2979523ramosetronConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61921RamosetronOne source FDA
- DrugBank DB09290One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C071315 | ramosetron | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7ZRO0SC54Y | RAMOSETRON | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q2979523 | ramosetron | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61921 | Ramosetron | One source FDA |
| DrugBank | DB09290 | — | One source Wikidata |
Also registered as ramosetron hydrochloride (UNII 9551LHD87E).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.